Kong-zhi Zhang

Comparison of response evaluation criteria in solid tumors (RECIST), European Association for the study of the liver (EASL) and modified RECIST criteria in evaluation of tumor response after transarteriai chemoembolization of primary liver cancer

Wenchang Yu, Kong-zhi Zhang, Shi-guang Chen, 2011 .

Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis

Xiaolong Wang, Chuanben Chen, Wenchang Yu, 2022, Gastroenterology report.

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma

Wenchang Yu, Kong-zhi Zhang, Weifu Liu, 2018, BMC Cancer.

Transarterial chemoembolization for unresectable hepatocellular carcinoma

Wenchang Yu, Kong-zhi Zhang, Weifu Liu, 2018, Medicine.

Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug‐eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma

Chuanben Chen, Wenchang Yu, Kong-zhi Zhang, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study

Wenchang Yu, Kong-zhi Zhang, Weifu Liu, 2018, Medicine.

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma

Wenchang Yu, Kong-zhi Zhang, Weifu Liu, 2018, BMC Cancer.

Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study.

Wenchang Yu, Kong-zhi Zhang, Weifu Liu, 2020, European journal of cancer.

Percutaneous transhepatic biliary drainage for obstructive jaundice caused by metastatic gastric cancer: efficacy and complications

Wenchang Yu, Kong-zhi Zhang, Mingzhi Hao, 2011 .

Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study

Xiaolong Wang, Wenchang Yu, Kong-zhi Zhang, 2023, Cancer Immunology, Immunotherapy.